SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

FORM 10-Q

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly period ended ~~August~~February 3129, ~~2011~~2012

o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____________ to _____________

Commission file number: 333-173508

SALIENT PRODUCTS CORPORATION

(Exact name of small business issuer as specified in its charter)

Nevada		27-4038696
(State or other jurisdiction of Incorporation or organization)		(I.R.S. Employer Identification No.)

1852 31st Street

San Diego, CA 92102

(Address of principal executive offices)

206-426-1775

(Issuer's telephone number)

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for at least the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “accelerated filer, large accelerated filer and smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	o	Accelerated filer	o
Non-accelerated filer	o	Smaller reporting company	x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

There were 10,000,000 shares of the Registrant’s $0.001 par value common stock outstanding as of ~~August~~April 313, ~~2011~~2012.

Salient Products Corporation

(A Development Stage Company)

Contents

Part I – Financial Information

Item 1.	FinaFinancial Statements	3

Item 2.	ManManagement’s Discussion and Analysis of Financial Condition and Results of Operation	12

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	14

Item 4T.	Controls and Procedures	14

Part II – Other Information

Item 1.	Legal Proceedings	15

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	15

Item 3.	Defaults Upon Senior Securities	15

Item 4.	Reserved	15

Item 5.	Other Information	15

Item 6.	Exhibits	15

Signatures		16

PART I—FINANCIAL INFORMATION

Statements in this Form 10-Q Quarterly Report may be “forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on our current expectations, estimates and projections about our business based, in part, on assumptions made by our management. These assumptions are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including those risks discussed in this Form 10-Q Quarterly Report, under “Management’s Discussion and Analysis of Financial Condition or Plan of Operation” and in other documents that we file with the Securities and Exchange Commission.

In addition, such statements could be affected by risks and uncertainties related to our financial condition, factors that affect our industry, market and customer acceptance, changes in technology, fluctuations in our quarterly results, our ability to continue and manage our growth, liquidity and other capital resource issues, competition, fulfillment of contractual obligations by other parties and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this Form 10-Q Quarterly Report, except as required by law.

Item 1. Financial Statements

Salient Products Corporation

(A Development Stage Corporation)

Financial Statements

As of ~~August~~February 3129, ~~2011~~2012 (unaudited)

and the Period November 19, 2010 (Date of Inception)

through ~~August~~February 3129, ~~2011~~2012 (unaudited)

Contents

Financial Statements:


Balance Sheets			4
Statements of Operations			5
Statements of Changes in Stockholders’ Deficit			6
Statements of Cash Flows			7
Notes to Financial Statements			8

Salient Products Corporation (A Development Stage Corporation) Balance Sheets

Salient Products Corporation
(A Development Stage Corporation)
Balance Sheets
	For the Three Months Ended February 29, 2012			November 30, 2011
	(Unaudited)			(Audited)

ASSETS

Current Assets:

Cash and cash equivalents	$	445		$	770

Total Current Assets		445			770

TOTAL ASSETS	$	445		$	770

LIABILITIES AND STOCKHOLDER’S (DEFICT) EQUITY

Current Liabilities:

Accounts payable and accrued expenses		5,119			--

Total Current Liabilities		5,119			--

TOTAL LIABILITIES		5,119			--

Stockholder’s (Deficit) Equity:

Preferred stock; $.001 par value; 5,000,000 shares authorized; 0 shares issued and outstanding		--			--

Common stock; $.001 par value; 70,000,000 shares authorized; 10,000,000 shares issued and outstanding		10,000			10,000

Accumulated deficit during development stage		(14,674	)		(9,230	)

Total Stockholder’s (Deficit) Equity		(4,674	)		770

TOTAL LIABILITIES AND STOCKHOLDER’S (DEFICIT) EQUITY	$	445		$	770

	August 31, 2011			November 30, 2010
	(unaudited)			(audited)
ASSETS
Current Assets
Cash and cash equivalents	$	3,839		$	10,000
Total Current Assets		3,839			10,000
TOTAL ASSETS	$	3,839		$	10,000
LIABILITIES AND STOCKHOLDER’S EQUITY
Current Liabilities
Accounts payable and accrued expenses	$	1,125		$	--
Total Current Liabilities		1,125			--
TOTAL LIABILITIES		1,125			--
Stockholder’s Equity
Preferred Shares; $.001 par value; 5,000,000 shares authorized; 0 shares issued and outstanding
Common stock; $.001 par value; 75,000,000 shares authorized; 10,000,000 shares issued and outstanding		10,000			10,000
Accumulated deficit during development stage		(7,286	)		--
Total Stockholder’s Equity		2,714			10,000
TOTAL LIABILITIES AND STOCKHOLDER’S EQUITY	$	3,839		$	10,000

The Accompanying notes are an integral part of the financial statements

Salient Products Corporation (A Development Stage Company) Statements of Operation For the Three and Ninth Month Periods Ended August 31, 2011 and for the period from November 19, 2010 (date of inception) through August 31, 2011

							November 19, 2010
	For the Three Months Ended			For the Nine Months Ended			(inception)
							through
	August 31,			August 31,			August 31,
	2011			2011			2011
	(unaudited)			(unaudited)			(unaudited)
Revenues	$	--		$	--		$	--
EXPENSES
Operating Expenses
General and administrative		1,130			2,536			2,536
Professional		750			4,750			4,750
Total operating expenses		1,880			7,286			7,286
Net loss from operations		(1,880	)		(7,286	)		(7,286	)
NET LOSS	$	(1,880	)	$	(7,286	)	$	(7,286	)
BASIC AND DILUTED LOSS PER SHARE	$	(0.00	)	$	(0.00	)		(0.00	)
WEIGHTED AVERAGE NUMBER OF
SHARES OUTSTANDING		10,000,000			10,000,000			10,000,000

The accompanying notes are an integral part of the financial statements.

Salient Products Corporation
(A Development Stage Company)

Statements of Operations
	For the Three Months Ended February 29, 2012			For the Three Months Ended February 28, 2011			For the Period Nov. 19, 2010, (date of inception) through Feb. 29, 2012

Revenues	$	--		$	--		$	--

EXPENSES

Operating Expenses
General and administrative		3,194			500			6,574
Professional		2,250			--			8,100
Total operating expenses		5,444			500			14,674

Net loss from operations		(5,444	)		(500	)		(14,674	)

NET LOSS	$	(5,444	)	$	(500	)	$	(14,674	)


BASIC AND DILUTED LOSS PER SHARE	$	(0.00	)	$	(0.00	)

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING		10,000,000			10,000,000

.The accompanying notes are an integral part of the financial statements.

Salient Products Corporation (A Development Stage Corporation) Statement of Stockholder’s Equity for the Period November 19, 2010 (date of inception) through August 31, 2011

Salient Products Corporation
(A Development Stage Corporation)
STATEMENT OF STOCKHOLDER'S EQUITY
							Accumulated
					Additional		Deficit
	Common Stock				Paid in		Development
	Shares		Amount		Capital		Stage			Total

Balance at Inception, November 19, 2010		--	$	--	$	--	$	--		$	--
Issuance of common stock for cash (November 19, 2010)		10,000,000		10,000		--		--			10,000

Net loss for the period Nov. 19, 2010 (date of inception) through Nov. 30, 2010				--		--		--			--

Balance, November 30, 2010		10,000,000	$	10,000	$	--	$	--		$	10,000

Net loss				--		--		(9,230	)		(9,230	)

Balance, November 30, 2011		10,000,000	$	10,000	$		$	(9,230	)	$	770

Net Loss (unaudited)				--		--		(5,444	)		(5,444	)

Balance, February 29, 2012		10,000,000	$	10,000	$	--	$	(14,674	)	$	(4,674	)

							Accumulated
					Additional		Deficit
	Common Stock				Paid in		Development
	Shares		Amount		Capital		Stage			Total
Balance at Inception, November 19, 2010		--	$	--	$	--	$	--		$	--
Issuance of common stock for cash (November 19, 2010)		10,000,000		10,000		--		--			10,000
Net loss for the period Nov. 19, 2010 (date of inception) through November 30, 2010				--		--		--			--
Balance, November 30, 2010		10,000,000	$	10,000	$	--	$	--		$	10,000
Net loss for the nine months ended August 31, 2011 (unaudited)				--		--		(7,286	)		(7,286	)
Balance, August 31, 2011		10,000,000	$	10,000	$	--	$	(7,286	)	$	2,714

The accompanying notes are an integral part of the financial statements.

Salient Products Corporation (A Development Stage Corporation) Statement of Cash Flows

Salient Products Corporation
(A Development Stage Corporation)
STATEMENT OF CASH FLOWS
	For the Three Months Ended February 29, 2012			For the Three Months ended February 28. 2011			For the Period Nov. 19, 2010 (date of inception) through Feb. 29, 2012
	(Unaudited)			(Unaudited)			(Unaudited)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$	(5,444	)	$	(500	)	$	(14,674	)
Changes in assets and liabilities:
Accounts payable and accrued expenses		5,119			--			5,119
Net Cash Used in Operating Activities		(325	)		(500	)		(9,555	)

CASH FLOWS FROM INVESTING ACTIVITIES:
Net Cash Used in Investing Activities		--			--			--

CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of common stock		--			--			10,000
Net Cash Provided by Financing Activates		--			--			10,000

Net increase (decrease) in cash and cash equivalents		(325	)		(500	)		(9,555	)
Cash and cash equivalents, beginning of period		770			10,000			--
Cash and cash equivalents, end of period	$	445		$	9,500		$	445

Supplemental Cash Flow Information
Cash paid for interest		--			--			--
Cash paid for taxes		--			--			--

	For the six months ended August 31, 2011			November 19, 2010 (inception) through August 31, 2011
	(unaudited)			(unaudited)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$	(7,286	)	$	(7,286	)
Changes in assets and liabilities:
Accounts payable and accrued expenses		1,125			1,125
Net Cash Used in Operating Activities		(6,161	)		(6,161	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net Cash Used in Investing Activities		--			--
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of common stock		--			10,000
Net Cash Provided by Financing Activates		--			10,000
Net increase (decrease) in cash and cash equivalents		(6,161	)		(3,839	)
Cash and cash equivalents, beginning of period		10,000			--
Cash and cash equivalents, end of period	$	3,839		$	3,839
Supplemental Cash Flow Information
Cash paid for interest	$	--		$	--
Cash paid for taxes	$	--		$	--

The accompanying notes are an integral part of the financial statements.

Salient Products Corporation

(A Development Stage Corporation)

Notes to Financial Statements

~~For the Period from November 19, 2010~~ (~~Date of Inception~~unaudited) ~~through August 31, 2011~~

For the three months ended February 29, 2012 and 2011

1. Background Information.

Salient Products Corporation was incorporated in the State of Nevada on November 19th, 2010. Salient Products Corporation is a development stage company with a principal business objective of selling computer software programs. The Company plans to have its initial software product be a PC-based software application for end users. The software application will be a module that allows the end-user to control multiple social networking and digital content online accounts in one place. This will be of particular interest to end users who want to have one central location to control their multiple online accounts for entertainment, social networking, blogging, and more.

We plan to stay on the cutting edge of the constantly changing online and software application market and our goal is to create a quality reputation within the software community and marketplace. Salient Products conducted research on various marketing venues and plans to sell our initial applications through our own online retail website to end users who want to manage their multiple accounts with other online providers from one central software application.

2. Financial Statements

In the opinion of management, all adjustments consisting only of normal recurring adjustments necessary for a fair statement of (a) the results of operations for the three ~~and nine~~ month ~~periods~~period ended ~~August~~February 3129, ~~2011~~2012, (b) the financial position at ~~August~~February 3129, ~~2011~~2012 and (c) cash flows for the ~~six~~three month period ended ~~August~~February 3129, ~~2011~~2012, have been made. The unaudited financial statements and notes are presented as permitted by Form 10-Q. Accordingly, certain information and note disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted. The accompanying financial statements and notes should be read in conjunction with the Company’s Form S-1/A for the fiscal year ended November 30, ~~2010~~2011. The results of operations for the three ~~and six~~ month period ended ~~August~~February 3129, ~~2011~~2012 are not necessarily indicative of those to be expected for the entire year.

3. Going Concern.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. For the period ended ~~August~~February 3129, ~~2011~~2012, the Company has had no operations. As of ~~August~~February 3129, ~~2011~~2012, the Company has not emerged from the development stage. In view of these matters, the Company’s ability to continue as a going concern is dependent upon the Company’s ability to begin operations and to achieve a level of profitability. The Company intends on financing its future development activities and its working capital needs largely from the sale of public equity securities with some additional funding from other traditional financing sources, including term notes until such time that funds provided by operations are sufficient to fund working capital requirements. The financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.

34. Significant Accounting Policies.

The significant accounting policies followed are:

FASB Codification - In June 2009, the FASB issued ASC 105, Generally Accepted Accounting Principles, effective for interim and annual reporting periods ending after September 15, 2009. This statement establishes the Codification as the source of authoritative accounting principles used in the preparation of financial statements in conformity with generally accepted accounting principles. The Codification does not replace or affect guidance issued by the SEC or its staff. As a result of the Codification, the references to authoritative accounting pronouncements included herein in our Form 10-Q now refer to the Codification topic section rather than a specific accounting rule as was past practice.

Use of estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and cash equivalents - All cash, other than held in escrow, is maintained with a major financial institution in the United States. Deposits with this bank may exceed the amount of insurance provided on such deposits. Temporary cash investments with an original maturity of three months or less are considered to be cash equivalents.

Research and development expenses - Expenditures for research, development, and engineering of products are expensed as incurred.

Common stock - The Company records common stock issuances when all of the legal requirements for the issuance of such common stock have been satisfied.

Revenue and cost recognition – - The Company has no current source of revenue; therefore the Company has not yet adopted any policy regarding the recognition of revenue or cost.

Advertising Costs - The Company’s policy regarding advertising is to expense advertising when incurred.

Income Taxes - Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes resulting from temporary differences. Such temporary differences result from differences in the carrying value of assets and liabilities for tax and financial reporting purposes. The deferred tax assets and liabilities represent the future tax consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

The Company adopted the provisions of FASB ASC 740-10 “Uncertainty in Income Taxes” (ASC 740-10), on January 1, 2007. The Company has not recognized a liability as a result of the implementation of ASC 740-10. A reconciliation of the beginning and ending amount of unrecognized tax benefits has not been provided since there is no unrecognized benefit since the date of adoption. The Company has not recognized interest expense or penalties as a result of the implementation of ASC 740-10. If there were an unrecognized tax benefit, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.

Earnings (Loss) Per Share - Basic loss per share is computed by dividing net loss attributable to common stockholders by the weighted average common shares outstanding for the period. Diluted loss per share is computed giving effect to all potentially dilutive common shares. Potentially dilutive common shares may consist of incremental shares issuable upon the exercise of stock options and warrants and the conversion of notes payable to common stock. In periods in which a net loss has been incurred, all potentially dilutive common shares are considered anti*dilutive and thus are excluded from the calculation. At ~~August~~February 3129, ~~2011~~2012, the Company did not have any potentially dilutive common shares.

Financial instruments –- In September 2006, the Financial Accounting Standards Board (FASB) introduced a framework for measuring fair value and expanded required disclosure about fair value measurements of assets and liabilities. The Company adopted the standard for those financial assets and liabilities as of the beginning of the 2008 fiscal year and the impact of adoption was not significant. FASB Accounting Standards Codification (ASC) 820 “Fair Value Measurements and Disclosures” (ASC 820) defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

Level 1 -	Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
Level 2 -	Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3 -	Inputs that are both significant to the fair value measurement and unobservable.

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of ~~August~~February 3129, ~~2011~~2012. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include accounts receivable, other current assets, accounts payable, accrued compensation and accrued expenses. The fair value of the Company’s notes payable is estimated based on current rates that would be available for debt of similar terms which is not significantly different from its stated value.

On November 19, 2010, the Company applied ASC 820 for all non-financial assets and liabilities measured at fair value on a non-recurring basis. The adoption of ASC 820 for non-financial assets and liabilities did not have a significant impact on the Company’s financial statements.

Recent accounting pronouncements

In October 2009, the Financial Accounting Standards Board (“FASB”) issued new guidance for revenue recognition with multiple deliverables. This new guidance impacts the determination of when the individual deliverables, included in a multiple-element arrangement may be treated as separate units of accounting. Additionally, it modifies the manner in which the transaction consideration is allocated across the separately identified deliverables by no longer permitting the residual method of allocating arrangement consideration. This new guidance is effective for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010, however early adoption is permitted. The adoption of this guidance will not have a material effect on the financial statements.

In January 2010, the FASB issued new guidance, which improves disclosures about fair value measurements. The new standard is effective for interim and annual periods beginning after December 15, 2009, except for certain disclosures regarding Level 3 measurements, which are effective for fiscal years beginning after December 15, 2010. The Company is evaluating the impact of this guidance on its financial statements and does not expect this new guidance to have a material effect on the financial statements.

In February 2010, the FASB issued updated guidance to address certain implementation issues related to an entity’s requirements to perform and disclose subsequent events. This update requires SEC filers to evaluate subsequent events through the date the financial statements were issued and exempts SEC filers from disclosing the date through which subsequent events have been evaluated. The updated guidance was effective upon issuance, and did not have a material impact on the Company’s financial statements.

Other recent accounting pronouncements issued by FASB (including EITF), the AICPA and the SEC did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

45. Income Taxes.

There is no current or deferred income tax expense or benefit for the periods ~~ending~~ended ~~November~~February 3029, ~~2010~~2012 and ~~August~~February 3128, 2011 and from November 19, 2010 (date of inception) through February 29, 2012.

The provision for income taxes is different from that which would be obtained by applying the statutory federal income tax rate to income before income taxes. The items causing this difference are as follows:

	For The Nine Months Ended August 31, 2011			Nov. 19, 2010 (Date of Inception) through Nov. 30, 2010
	For the Three Months Ended February 29, 2012			For the Three Months Ended February 28, 2011			For the Period Nov. 19, 2010 (date of inception) through Feb. 29, 2012
Tax benefit at U.S. statutory rate	$	2,500.		$	---
	(Unaudited)			(Unaudited)			(Unaudited)
State income tax benefit, net of federal benefit		200.			---
Tax benefit at U.S. statutory rate	$	1,851		$	170		$	4,989
Valuation allowance		(2,700.	)		---
State income tax benefit, net of federal benefit		163			15			440
Tax Benefit	$	---		$	---
Valuation allowance	$	(2,014	)	$	(185	)	$	(5,429	)
Tax benefit	$	--		$	--		$	--

The Company did not have any temporary differences for the period from November 19, 2010 (date of inception) through ~~November~~February 3029, ~~2010 (audited), or for the nine months ended August 31, 2011 (unaudited)~~2012.

56. Stock Subscription and Related Party Transactions

On November 19, 2010, the Company sold 10,000,000 shares of its $0.001 common stock to an officer of the Company for a $10,000 stock subscription receivable.

The officers and directors of the Company are involved in other business activities and may, in the future, become involved in other business opportunities that become available. They may face a conflict in selecting between the Company and other business interests. The Company has not formulated a policy for the resolution of such conflicts.

The Company does not own or lease property or lease office space. The office space used by the Company was arranged by the founder of the Company to use at no charge.

The above amount is not necessarily indicative of the amount that would have been incurred had a comparable transaction been entered into with independent parties.

Item 2. Management’s Discussion and Analysis or Plan of Operation.

Forward Looking Information

Information contained in the following discussion of results of operations and financial condition and in certain of the notes to the financial statements included in this document contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which can be identified by the use of words such as “may,”“will,” “expect,” “anticipate,” “estimate,” or “continue,” or variations thereon or comparable terminology. In addition, all statements other than statements of historical facts that address activities, events, or developments the Company expects, believes, or anticipates will or may occur in the future, and other such matters, are forward-looking statements. The following discussion should be read in conjunction with the Company’s unaudited financial statements and related notes included elsewhere herein.

The Company’s future operating results may be affected by various trends and factors, which are beyond the Company’s control. The important factors that could prevent us from achieving our stated goals and objectives include, but are not limited to, those set forth in our Form S-1/A filed with the Commission on August 30, 2011. We undertake no responsibility or obligation to update publicly these forward-looking statements, but may do so in the future in written or oral statements. Investors should take note of any future statements made by or on our behalf. The Company cautions the reader that a number of important factors discussed herein, and in other reports filed with the Commission could affect the Company’s actual results and cause actual results to differ materially from those discussed in forward-looking statements.

Overview

The Company currently has not developed or sold any products but is in the development stage for its products. Without sufficient additional financing, the Company will not be able to complete the development or introduce its software to the market and may have to discontinue operations.

Liquidity and Capital Resources

We have not generated positive cash flows from operating activities. The primary source of capital has been from the sale of equity securities. Our primary use of capital has been for professional fees, and general and administrative costs. Our working capital requirements are expected to increase in line with the growth of our business.

We have no lines of credit or other bank financing arrangements. We expect that working capital requirements will be funded through a combination of our existing funds, cash flow from operations and issuance of equity and debt securities.

As of ~~August~~February 3129, ~~2011~~2012, the Company had $~~3,839~~445 in cash and total assets compared to $~~10,000~~770 in cash and total assets ~~of $10,000~~ as of November 30, ~~2010~~2011.

During the three months ended ~~August~~February 3129, ~~2011~~2012, net cash used in operating activities was $~~3,005~~325.

On November 19, 2010 the Company issued 10,000,000 shares to an Officer and Director for total proceeds of $10,000. Without sufficient additional financing, the Company will not be able to complete the development and introduce its software to the market and may have to discontinue operations.

Financings, if available, may be on terms that are dilutive or potentially dilutive to our stockholders, and the prices at which new investors would be willing to purchase our securities may be lower than earlier investor’s prices. The holders of new securities may also receive rights, preferences or privileges that are senior to those of existing holders of our securities. If new sources of financing are required but are insufficient or unavailable, we would be required to modify our growth and operating plans to the extent of available funding, which would harm our ability to grow our business. The Company needs an immediate cash infusion that if not received could mean that current operations may cease.

Requirement for Additional Capital

As of ~~August~~February 3129, ~~2011~~2012, the Company had $~~3,839~~445 in cash and total assets compared to $~~10,000~~770 in cash and total assets ~~of $10,000~~ as of November 30, ~~2010~~2011.

During the three months ended ~~August~~February 3129, ~~2011~~2012, net cash used in operating activities was $3325.~~005.~~

We plan to complete our milestones as follows:

0- 3 MONTHS

Management will concentrate on the completion of the Registration Statement as well as utilizing third party experts for graphical design and beginning software development of software applications. We estimate this will cost approximately $5,000 and have budgeted this cost in the Wages/Contractor line item in the Use of Proceeds. At this time, no verbal or written contracts have been made with any third parties. We also plan to continue with software development of current designs and estimate this will cost approximately $2,000 and this amount is budgeted in the Product Development line item in the Use of Proceeds. Salient Products also plans to explore online marketing options and interview software and web developers. The Company does not anticipate any fees associated with these duties and if any costs do arise they will come from the Working Capital line item in the Use of Proceeds.

4-6 MONTHS

During months 4-6 the Company will focus on developing our Online Marketing Website. Salient Products has secured the domain name www.salientproducts.com. According to the Web Design Cost Calculator found at http://www.howmuchdoesawebsitecost.com/, corporate web sites like the one that we desire start at around $3,000 if we utilize US Developers. We have decided to keep the design to a minimum and as such the cost would be approximately $3,000 and is budgeted in the Sales and Marketing line item of the Use of Proceeds. The site that is planned will provide for easy navigation, display of all products, and concise company information and will be a fully functional website. The Company will continue to design and develop its PC-based software applications during this period as well. We have budgeted $6,000 from Wages/Contractor line item to address this item. The Company plans to start negotiations for an online merchant account during this timeframe.

7-9 MONTHS

During this period we anticipate software development costs to decrease and the costs of software testing, Quality Assurance and Marketing costs to increase. These costs are approximated at $5000 are budgeted in the Product Development line item of the Use of Proceeds. We anticipate that our web site’s initial design will be complete but we will want to add E-Commerce to the site during this period. The website will integrate a “shopping cart” for online sales and we will determine online marketing venues such as Google, Amazon and other vertical market venues such as software sites like www.software.com where we potentially could be listed among software titles from other companies. Based on the website resource mentioned above Web Design Cost Calculator found at (http://www.howmuchdoesawebsitecost.com/), the price difference from a basic designed website and an E-Commerce-enabled site is approximately $2,000. The Company estimates it will cost approximately $2,000 for this project and this budgeted in the Sales and Marketing line item of the Use of Proceeds. Once the ecommerce functionality is added to the Company’s website, the website will be able to display company information, all products, and be robust enough to generate significant online sales. While it is possible that the cost to build a fully functional website could greatly exceed $9,000, we are confident that the budgeted $5,000 to $9,000 for the website is sufficient and will provide us with a website that can generate a significant amount of sales.

10-12 MONTHS

Salient Products is hopeful that during this period we will launch the initial version of our PC-based software application for public sale on our web site. We will continue to analyze online marking efforts and make necessary changes for increasing sales. Updates to the web site to increase sales are estimated at $2,000 and the Company has allocated $1,000 from the Sales and Marketing budget and $1,000 from the Wages/Contractor budget to address the plans listed. Future long-term plans are to prepare a detailed two year marketing and software development plan to launch software updates and possibly new software applications on a regular basis after sales warrant growth of this type.

Item 3. Qualitative and Quantitative Disclosures About Market Risk.

Not applicable.

Item 4T. Controls and Procedures.

Evaluation of disclosure controls and procedures

Our Chief Executive Officer and Chief Financial Officer (collectively the “Certifying Officers”) maintain a system of disclosure controls and procedures that is designed to provide reasonable assurance that information, which is required to be disclosed, is accumulated and communicated to management timely. The Certifying Officers have concluded that the disclosure controls and procedures are effective at the “reasonable assurance” level. Under the supervision and with the participation of management, as of the end of the period covered by this report, the Certifying Officers evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act). Furthermore, the Certifying Officers concluded that our disclosure controls and procedures in place are designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported on a timely basis in accordance with applicable Commission rules and regulations; and (ii) accumulated and communicated to our management, including our Certifying Officers and other persons that perform similar functions, if any, to allow us to make timely decisions regarding required disclosure in our periodic filings.

Changes in Internal Control Over Financial Reporting

No change in the Company’s internal control over financial reporting occurred during the three months ended ~~August~~February 3129, ~~2011~~2012, that materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

As of the date of this Quarterly Report, neither we nor any of our officers or directors is involved in any litigation either as plaintiffs or defendants. As of this date, there is not any threatened or pending litigation against us or any of our officers or directors.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Not Applicable.

Item 3. Defaults Upon Senior Securities.

None

Item 4. Reserved

Item 5. Other Information

The Company does not have any other material information to report with respect to the three month period ended ~~August~~February 3129, ~~2011~~2012.

Item 6. Exhibits

Exhibits: The following exhibits are filed with this report:

31.1

Certification pursuant to Rule 13a-14(a) or 15d-14(a) under The Securities Exchange Act of 1934 as amended.

32.1

Certifications pursuant to 18 U.S.C section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101* The following financial information from our Quarterly Report on Form 10-Q for the quarter ended ~~August~~February 3129, ~~2011~~2012 formatted in Extensible Business Reporting Language (XBRL): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Stockholder's Equity, (iv) the Consolidated Statements of Cash Flows, and (v) Notes to Consolidated Financial Statements

* In accordance with Rule 406T of Regulation S-T, the XBRL information in Exhibit 101 to this quarterly report on Form 10-Q shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (Exchange Act), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, as amended, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Salient Products Corporation
Date: October 12, 2011	By:	/s/ Shehzad Peermahomed
Date:April 13, 2012	By:	/s/ Shehzad Peermahomed
		Shehzad Peermahomed,
		Chief Executive Officer and Principal Accounting Officer

Filing Compare · Salient Products Corp